000 01315 a2200421 4500
005 20250514211823.0
264 0 _c20050203
008 200502s 0 0 eng d
022 _a0394-3402
040 _aNLM
_beng
_cNLM
100 1 _aTesta, R
245 0 0 _aEffect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.
_h[electronic resource]
260 _bDiabetes, nutrition & metabolism
_cAug 2004
300 _a217-21 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aDiabetes Mellitus, Type 2
_xblood
650 0 4 _aDietary Supplements
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlasminogen Activator Inhibitor 1
_xgenetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aVitamin E
_xpharmacology
700 1 _aBonfigli, A R
700 1 _aSirolla, C
700 1 _aBoemi, M
700 1 _aManfrini, S
700 1 _aMari, D
700 1 _aTesta, I
700 1 _aSacchi, E
700 1 _aFranceschi, C
773 0 _tDiabetes, nutrition & metabolism
_gvol. 17
_gno. 4
_gp. 217-21
999 _c15260514
_d15260514